Skip to main content

Biogen Inc. (NASDAQ: BIIB) Investor Securities Class Action Lawsuit 02/09/2022

  • If you purchased a significant amount of shares of Biogen Inc. (NASDAQ: BIIB) between June 7, 2021 and January 11, 2022, and / or if you purchased any NASDAQ: BIIB shares prior to June 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: April 8, 2022. NASDAQ: BIIB investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 29, 2023 - The court issued an order granting the motion to dismiss and dismissed the case with prejudice. July 27, 2022 - A motion was filed to dismiss the amended complaint. June 27, 2022 - An amended complaint was filed. February 9, 2022 - An investor in shares of Biogen Inc. (NASDAQ: BIIB) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alle...

You must register (for free) or login to view the entire case.